Eton Pharmaceuticals Receivables

Eton Pharmaceuticals (ETON) currently reports a receivables of $13M as of March 2026. That compares with $16M in the prior-year period — down 18.2% year over year. Use the charts on this page to explore Eton Pharmaceuticals's receivables history and peer comparisons.

Eton Pharmaceuticals's receivables decreased from $16M to $13M — a 18.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eton Pharmaceuticals reported $13M in receivables as of March 2026. That compares with $16M in the prior-year period — down 18.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eton Pharmaceuticals, and consider following ETON for alerts when major investors trade the stock.

Eton Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ETON with unrelated industries.